Journal: Redox Biology

Article Title: Quercetin improves retinal glycolysis to slow myopia progression through orchestrating the AKT/FOXO/HK2 axis

doi: 10.1016/j.redox.2026.104139

Figure Lengend Snippet: Multi-omics analysis of the regulation of glycolysis by PI3K/AKT/FOXO signaling pathway in myopic retina. A-C. The distribution of HK2, PFKL, and PKM in various retinal cell types was analyzed by single-cell sequencing. D. UMAP visualization of the transcriptomic diversity of the retina. Cell types are shown in different colors. E-G. Heat maps of HK2, PFKL, and PKM expression levels in various retinal cell types were analyzed by single-cell sequencing. H. KEGG analysis of differentially expressed genes in retinal single-cell RNA sequencing. I. Heat map of proteomic analysis results. J. Heat maps of phosphorylated proteomics analysis. K. Phosphorylated proteomics KEGG analysis results. L. Proteomic KEGG analysis results. M. HK2, PFKL, and PKM2 expression were detected by Western blot in NC-OS, NC-OD, LIM-OS, and LIM-OD. Samples derived from the same experiment and that blots were processed in parallel. N. PIK3Ca, p -PIK3Ca, AKT1, p -AKT1,FOXO3a, and p -FOXO3a expression detected by Western blot in NC-OS, NC-OD, LIM-OS, and LIM-OD. Samples derived from the same experiment and that blots were processed in parallel. O-T. Bar graphs of Western blot analysis for PIK3Ca、p- PIK3Ca 、AKT1、p-AKT1, FOXO3a, and p -FOXO3a in NC-OS, NC-OD, LIM-OS and LIM-OD (∗∗∗P < 0.001). U-X. Bar graphs of Western blot analysis for HK2, PFKL, and PKM2 in NC-OS, NC-OD, LIM-OS, and LIM-OD (∗∗∗P < 0.001). Y. Bar graphs of LA analysis in NC-OS, NC-OD, LIM-OS and LIM-OD groups (∗∗∗P < 0.001, ∗P < 0.05). Z. Bar graphs of LAHA analysis in NC-OS, NC-OD, LIM-OS and LIM-OD groups (∗∗∗P < 0.001, ∗P < 0.05).

Article Snippet: AKT1 , 1:300 , bs0115R, Bioss, China.

Techniques: Biomarker Discovery, Single Cell, Sequencing, Expressing, RNA Sequencing, Western Blot, Derivative Assay

Journal: Redox Biology

Article Title: Quercetin improves retinal glycolysis to slow myopia progression through orchestrating the AKT/FOXO/HK2 axis

doi: 10.1016/j.redox.2026.104139

Figure Lengend Snippet: Gene and protein interaction analysis. A, B. AKT1-HK2, FOXO3a-HK2 molecular docking. C. Dual luciferase analysis of FOXO3 regulation of HK2. D. The protein interactions between AKT1 and HK2, FOXO3a and HK2 were analyzed by co-immunoprecipitation.

Article Snippet: AKT1 , 1:300 , bs0115R, Bioss, China.

Techniques: Luciferase, Immunoprecipitation

Journal: Redox Biology

Article Title: Quercetin improves retinal glycolysis to slow myopia progression through orchestrating the AKT/FOXO/HK2 axis

doi: 10.1016/j.redox.2026.104139

Figure Lengend Snippet: Quercetin inhibits the PI3K signaling pathway and affects glycolysis. A.PIK3Ca、p- PIK3Ca 、AKT1、p-AKT1, FOXO3a, p -FOXO3a, HK2, PFKL, PKM2 and LDHA expression detected by Western blot in NC, LIM, DMSO, Que-L, Que-M, Que-H group in 4w and 6w. Samples derived from the same experiment and that blots were processed in parallel. B–U. Bar graphs of Western blot analysis for PIK3Ca、p- PIK3Ca 、AKT1、p-AKT1, FOXO3a, p -FOXO3a, HK2, PFKL, PKM2, and LDHA in NC, LIM, DMSO, Que-L, Que-M, Que-H group in 4w and 6w. (∗∗∗P < 0.001). V. PIK3Ca, AKT1, FOXO3a immunofluorescence staining in NC, LIM, DMSO, Que-L, Que-M, Que-H group in 4w and 6w. W. HK2, PFKL, and LDHA immunofluorescence staining in NC, LIM, DMSO, Que-L, Que-M, Que-H group in 4w and 6w.

Article Snippet: AKT1 , 1:300 , bs0115R, Bioss, China.

Techniques: Expressing, Western Blot, Derivative Assay, Immunofluorescence, Staining

Journal: Genes & Diseases

Article Title: MFAP2 promotes metastasis and drug resistance by regulating epithelial-to-mesenchymal transition through EGFR signaling pathway in colorectal cancer cells

doi: 10.1016/j.gendis.2025.101800

Figure Lengend Snippet: MFAP2 promotes epithelial–mesenchymal transition (EMT) through the EGFR-AKT-STAT3 signaling pathway in colorectal cancer (CRC) cells. (A, B) The top 20 enrichment signaling pathways regulated by MFAP2 knockdown. (C, D) VEGFR2 signaling pathway was enriched in the MFAP2 knockdown cells, shown by Gene Set Enrichment Analysis (GSEA) and essential genes in this enrichment. (E) MFAP2 knockdown affected the EGFR-AKT-STAT3 axis.

Article Snippet: Following blocking with 5% non-fat milk in PBS with 0.02% Tween 20 detergent (PBST) at room temperature for 2 h, the membranes were incubated with primary antibodies, including MFAP2 (Solarbio, China), GAPDH (BBI Co., Ltd., China), epidermal growth factor receptor (EGFR; Proteintech, China), protein kinase B (AKT) (Proteintech), signal transducer and activator of transcription 3 (STAT3) (Proteintech), and vascular endothelial growth factor A (VEGFA) (Proteintech), p-EGFR (Cell Signaling Technology, USA), p-STAT3 (Cell Signaling Technology), and p-AKT ser473 (Cell Signaling Technology) antibodies, at 4 °C overnight.

Techniques: Protein-Protein interactions, Knockdown

Journal: International Journal of Oncology

Article Title: Hypoxia-induced exosomal CAMTA1 promotes radio-resistance in MDA-MB-231 cells by regulating NRG1 to mediate M2 macrophage polarization

doi: 10.3892/ijo.2026.5875

Figure Lengend Snippet: Exosomal CAMTA1 promotes tumor growth in vivo . (A) The transfection efficacy of Ov-CAMTA1 was detected using RT-qPCR and immunoblotting analysis. (B) The appearance of tumor. The tumor (C) volume and (D) weight. (E) The mRNA expression of CAMTA1 was detected using RT-qPCR. (F) The level of IL-10 was detected using ELISA-related IL-10 assay kits. (G) The level of CD163 was detected using immunohistochemistry analysis. (H) H&E staining. (I) The expression of Caspase 3 was detected using immunohistochemistry analysis. (J) The Spearman correlation analysis of CAMTA1 and NRG1. (K) The expression of NRG1 was detected using immunohistochemistry analysis. * P<0.05, ** P<0.01 and *** P<0.001. CAMTA1, Calmodulin-binding Transcription Activator 1; Ov, overexpression; RT-qPCR, reverse transcription-quantitative PCR; H&E, hematoxylin and eosin; NRG1, neuregulin 1.

Article Snippet: The slices were then incubated with primary antibody against NRG1 (cat. no. 83323-6-RR; 1:500; Proteintech Group, Inc.), CD163 (cat. no. 83285-4-RR; 1:2,000; Proteintech Group, Inc.) and Caspase-3 (cat. no. 19677-1-AP; 1:500; Proteintech Group, Inc.) overnight at 4°C.

Techniques: In Vivo, Transfection, Quantitative RT-PCR, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Staining, Binding Assay, Over Expression, Reverse Transcription, Real-time Polymerase Chain Reaction